| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $9,369,571 ) |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 001 | 4 | NIH | 3/24/2025 | $150,000 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL167656 | Cardiovascular Risk of Antiretroviral Therapy Drugs in HIV | 000 | 3 | NIH | 3/31/2025 | $588,613 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | F32AR083823 | Deciphering the myofibroblast life cycle in skin wound healing | 000 | 2 | NIH | 3/17/2025 | $79,756 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 002 | 4 | NIH | 3/31/2025 | $1 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HD110990 | Development of a lacO/lacI based fluorescence reporter-operator system to study chromosome dynamics and double-strand break repair in mouse meiosis. | 000 | 3 | NIH | 2/13/2025 | $329,918 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG081855 | Mitochondrial NAD+ Metabolism in Cardiac Aging | 000 | 2 | NIH | 12/24/2024 | $539,182 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35HL145237 | Translational Control of Megakaryocyte and Platelet Gene Expression in Disease | 000 | 7 | NIH | 1/20/2025 | $641,012 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | U01AI176244 | Autoimmune Drivers and Protectors Team Science (ADAPTS) | 000 | 3 | NIH | 1/23/2025 | $1,249,430 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01NS135830 | Influence of neuromelanin on single dopaminergic neurons in Parkinson's disease. | 000 | 1 | NIH | 1/23/2025 | $616,200 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01EY034946 | Retinal Pigmented Epithelium Epigenome Dysregulation With Aging and Modulation by Diet | 000 | 2 | NIH | 1/23/2025 | $536,749 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AR080896 | PDGFRB Signaling in Progressive Skin Disease | 000 | 3 | NIH | 1/23/2025 | $476,629 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AI183676 | Defining the Regulatory Landscape of Lupus with CVD Comorbidity | 000 | 1 | NIH | 11/20/2024 | $793,093 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM152165 | Centromere behaviors that promote proper chromosome segregation in meiosis and mitosis | 001 | 2 | NIH | 12/10/2024 | $383,625 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL163095 | Novel lymphatic genes that regulate heart valve development and disease | 000 | 3 | NIH | 11/18/2024 | $480,910 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | K99AG086524 | Investigating TFEB as a critical node to improve proteostatic maintenance and skeletal muscle function with age | 000 | 1 | NIH | 11/22/2024 | $135,057 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL131652 | Defining the Mechanisms of Lymphatic Vascular Growth and Function | 000 | 8 | NIH | 11/6/2024 | $474,299 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG074502 | Determining the context specificity of metformin treatment on muscle mitochondria and healthspan | 001 | 4 | NIH | 12/19/2024 | $0 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG074502 | Determining the context specificity of metformin treatment on muscle mitochondria and healthspan | 000 | 4 | NIH | 12/18/2024 | $536,527 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AI168355 | Complement C5 inhibition as sepsis therapy | 000 | 4 | NIH | 3/21/2025 | $633,416 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 001 | 4 | NIH | 3/24/2025 | $100,000 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 001 | 4 | NIH | 3/24/2025 | $1 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01DE032911 | Aging and Oxidative Stress Influence Salivary Gland Disease in Sjogren's Syndrome | 000 | 3 | NIH | 3/5/2025 | $457,299 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R21AR084235 | MuRF1 substrates and mechanisms of skeletal muscle atrophy | 000 | 2 | NIH | 3/3/2025 | $168,795 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UM1AI144292 | Oklahoma ACE: Molecular Destruction of Autoimmune Disease to Aid Clinical Trail Success | 001 | 6 | NIH | 2/19/2025 | $20,984 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM152165 | Centromere behaviors that promote proper chromosome segregation in meiosis and mitosis | 000 | 1 | NIH | 11/21/2024 | $0 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 000 | 3 | NIH | 11/1/2024 | $0 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 000 | 3 | NIH | 11/1/2024 | $0 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 000 | 3 | NIH | 11/1/2024 | $0 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 000 | 3 | NIH | 11/1/2024 | $0 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM126980 | Understanding Cell Division | 000 | 6 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 000 | 3 | NIH | 11/1/2024 | $0 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM149343 | Mechanisms of cohesin regulation in vertebrates | 000 | 2 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM126980 | Understanding Cell Division | 002 | 6 | NIH | 3/24/2025 | $14,585 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG064951 | Does insulin sensitivity impact the potential of metformin to slow aging? | 000 | 5 | NIH | 3/4/2025 | $0 |
| | 2025 | 2023 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UM1AI144292 | Oklahoma ACE: Molecular Destruction of Autoimmune Disease to Aid Clinical Trail Success | 000 | 5 | NIH | 2/19/2025 | -$20,984 |
| | 2025 | 2023 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | CE152464 | Community Project Funding/Congressionally Directed Spending - Construction | 03 | 1 | HRSA | 12/19/2024 | $0 |
| | 2025 | 2023 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM142726 | Mechanisms of APP ectodomain function | 001 | 4 | NIH | 1/20/2025 | $3,464 |
| | 2025 | 2022 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R21DE031166 | Salivary gland response to innate immune mediators dictates Sjogren's syndrome development | 000 | 2 | NIH | 2/20/2025 | $0 |
| | 2025 | 2022 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R33AR078075 | Intraarticular microbial DNA as a novel mediator of osteoarthritis | 000 | 3 | NIH | 12/16/2024 | $0 |
| | 2025 | 2022 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL101917 | Protease Activated Receptor and Thrombomodulin Signaling by Coagulation Proteases | 000 | 12 | NIH | 1/31/2025 | $0 |
| | 2025 | 2022 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AI129458 | Characterization of a distinct NKT subset and its role in influenza responses | 000 | 5 | NIH | 11/22/2024 | $0 |
| | 2025 | 2022 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM126980 | Understanding Cell Division | 001 | 5 | NIH | 3/24/2025 | -$14,585 |
| | 2025 | 2021 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01EB025596 | A 3D human tissue-engineered lung model to study immune responses to Respiratory Syncytial Virus | 000 | 4 | NIH | 1/31/2025 | -$4,405 |
| | 2025 | 2020 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AR072401 | Mechanisms of Lupus Disease Transition and Hydroxychloroquine Immune Modulation | 000 | 4 | NIH | 10/16/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $39,320,289 ) (Continued on the next page) |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35HL144605 | Protease-Mediated Vascular Instability in Development and Disease | 001 | 6 | NIH | 6/14/2024 | $67,558 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | P30AR073750 | Oklahoma Rheumatic Disease Research Cores Center | 003 | 7 | NIH | 9/6/2024 | $852,500 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM126980 | Understanding Cell Division | 000 | 6 | NIH | 6/27/2024 | $460,350 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R21AR085344 | The peripheral blood microbiome as a potential biomarker of knee osteoarthritis | 001 | 1 | NIH | 9/26/2024 | $0 |
|
